N-(1-(3-acrylamidophenylsulfonyl)piperidin-4-yl)-4-(2-chloro-6-methoxybenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4535078

PubChem CID: 155547982

Max Phase: Preclinical

Molecular Formula: C28H28ClF3N6O8S

Molecular Weight: 587.06

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3OC)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C26H27ClN6O6S.C2HF3O2/c1-3-22(34)29-17-6-4-7-18(14-17)40(37,38)33-12-10-16(11-13-33)30-26(36)24-20(15-28-32-24)31-25(35)23-19(27)8-5-9-21(23)39-2;3-2(4,5)1(6)7/h3-9,14-16H,1,10-13H2,2H3,(H,28,32)(H,29,34)(H,30,36)(H,31,35);(H,6,7)

Standard InChI Key:  ZZNRPLKFYYMHKG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 47 49  0  0  0  0  0  0  0  0999 V2000
   10.7093  -22.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4170  -22.0020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0015  -22.0020    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.7093  -23.2278    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.9994  -22.8151    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.1247  -22.4106    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4170  -21.1848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5475  -25.2421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5516  -24.4249    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.8418  -24.8300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6567  -21.5937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4739  -21.5937    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2481  -20.8860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2481  -22.3014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4318  -22.2986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0233  -23.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320  -23.7142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2534  -23.7115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6582  -23.0041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0246  -21.5901    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.4754  -23.0006    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1083  -21.5937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8825  -20.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6997  -20.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9502  -20.1080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2877  -19.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6279  -20.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9255  -21.5937    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6997  -22.3014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3341  -22.3014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9244  -23.0071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3295  -23.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1470  -23.7169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5578  -23.0093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1510  -22.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3701  -24.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7730  -25.1413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5894  -25.1447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0015  -24.4380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5912  -23.7264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7761  -23.7265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9950  -25.8542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8121  -25.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2177  -26.5671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2238  -25.1517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0349  -26.5706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8870  -23.7066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  9  8  2  0
 10  9  2  0
 11 12  1  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 15 20  1  0
 19 21  1  0
 12 23  1  0
 24 22  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 23  2  0
 22 28  1  0
 22 29  2  0
 28 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33  9  1  0
  9 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 36  1  0
 38 42  1  0
 42 43  1  0
 43 44  1  0
 43 45  2  0
 44 46  2  0
 21 47  1  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 587.06Molecular Weight (Monoisotopic): 586.1401AlogP: 3.03#Rotatable Bonds: 9
Polar Surface Area: 162.59Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.75CX Basic pKa: 0.01CX LogP: 2.78CX LogD: 2.78
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.28Np Likeness Score: -1.76

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source